A genomic analysis platform that predicts therapeutic outcomes with unprecedented accuracy.
LEARN MOREOptimal guide RNA sequences with superior off-target prediction. Reduce failed experiments.
Generate antisense oligonucleotide sequences validated against FDA-approved drugs.
Predict gene essentiality before wet lab experiments. 98% accuracy vs. DepMap data.
Identify therapeutic targets computationally. Prioritize candidates before clinical investment.
We're raising a seed round and seeking strategic investors.